Evidence map›Paper›PMID 28053212›Full record

ArticleJournal of clinical microbiology2017

Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov.

J P Z Siqueira, D A Sutton, J Gené, D García, N Wiederhold, S W Peterson, J Guarro

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Name Changes for Fungi of Medical Importance, 2016-2017.Journal of clinical microbiology · 2019
    Pooled it
  2. Epoxidation of ent-pimara-8(14),15-dien-19-oic acid by whole cells of the endophytic fungus Aspergillus sclerotiorum.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Article
  4. BeyondAntimicrobial agents and chemotherapy · 2026
    Article
  5. Article
  6. Dual biocontrol potential of the entomopathogenic fungusSaudi journal of biological sciences · 2023
    Article
  7. Article
  8. Article
  9. Infection and drug resistance · 2020
    Article
  10. Antimicrobial agents and chemotherapy · 2018
    Article
  11. Taxonomy and evolution ofComputational and structural biotechnology journal · 2018
    Review
  12. Respiratory Failure WithJournal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

J P Z SiqueiraUnitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
D A SuttonFungus Testing Laboratory, University of Texas Health Science Center, San Antonio, Texas, USA.
J GenéUnitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain josepa.gene@urv.cat.ORCID 0000-0001-6195-9299
D GarcíaUnitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
N WiederholdFungus Testing Laboratory, University of Texas Health Science Center, San Antonio, Texas, USA.
S W PetersonMycotoxin Prevention and Applied Microbiology Research Unit, National Center for Agricultural Utilization Research, Peoria, Illinois, USA.
J GuarroUnitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
Institut de Recerca Biomèdica Catalunya Sud · ESThe University of Texas Health Science Center at San Antonio · USFaculdade de Medicina de São José do Rio Preto · BRNational Center for Agricultural Utilization Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multilocus phylogenetic study was carried out to assess species identity of a set of 34 clinical isolates from

Indexed as

PhylogenyAntifungal AgentsAspergillosisAspergillusCalmodulinCluster AnalysisDNA, FungalDNA, Ribosomal SpacerHumansMicrobial Sensitivity TestsRNA Polymerase IISequence Analysis, DNATubulinUnited StatesAntifungal AgentsCalmodulinDNA, FungalDNA, Ribosomal SpacerRNA Polymerase IITubulinAspergillusCircumdati sectionclinical isolatesmolecular identificationphenotypic identification

Identifiers

PMID28053212
PMCPMC5328464
OpenAlexW2569108528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.